Nonalcoholic fatty liver disease is a major public health burden. Although many features of nonalcoholic fatty liver disease pathogenesis are known, the specific mechanisms and susceptibilities that determine an individual's risk of developing nonalcoholic steatohepatitis versus isolated steatosis are not well delineated. The predominant and defining histologic and imaging characteristic of nonalcoholic fatty liver disease is the accumulation of lipids. Dysregulation of lipid homeostasis in hepatocytes leads to transient generation or accumulation of toxic lipids that result in endoplasmic reticulum (ER) stress with inflammation, hepatocellular damage, and apoptosis. ER stress activates the unfolded protein response(UPR)which is classically viewed as an adaptive pathway to maintain protein folding homeostasis. Recent studies have uncovered the contribution of the UPR sensors in the regulation of hepatic steatosis and in the cellular response to lipotoxic stress. Interestingly, theUPR sensors can be directly activated by toxic lipids, independently of the accumulation of misfolded proteins, termed lipotoxic and proteotoxic stress, respectively. The dual function of the UPR sensors in protein and lipid homeostasis suggests that these two types of stress are interconnected likely due to the central role of the ER in protein folding and trafficking and lipid biosynthesis and trafficking, such that perturbations in either impact the function of the ER and activate the UPR sensors in an effort to restore homeostasis. The precise molecular similarities and differences between proteotoxic and lipotoxic ER stress are beginning to be understood. Herein, we provide an overview of the mechanisms involved in the activation and cross-talk between the UPR sensors, hepatic lipid metabolism, and lipotoxic stress, and discuss the possible therapeutic potential of targeting the UPR in nonalcoholic fatty liver disease. (C) 2019 Published by Elsevier Inc.
机构:
Chulabhorn Royal Acad, Fac Med & Publ Hlth, HRH Princess Chulabhorn Coll Med Sci, Bangkok 10210, Thailand
Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok 10400, ThailandChulabhorn Royal Acad, Fac Med & Publ Hlth, HRH Princess Chulabhorn Coll Med Sci, Bangkok 10210, Thailand
Chienwichai, Peerut
Reamtong, Onrapak
论文数: 0引用数: 0
h-index: 0
机构:
Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok 10400, ThailandChulabhorn Royal Acad, Fac Med & Publ Hlth, HRH Princess Chulabhorn Coll Med Sci, Bangkok 10210, Thailand
Reamtong, Onrapak
论文数: 引用数:
h-index:
机构:
Boonyuen, Usa
Pisitkun, Trairak
论文数: 0引用数: 0
h-index: 0
机构:
Chulalongkorn Univ, Ctr Excellence Syst Biol, Fac Med, Bangkok 10330, ThailandChulabhorn Royal Acad, Fac Med & Publ Hlth, HRH Princess Chulabhorn Coll Med Sci, Bangkok 10210, Thailand
Pisitkun, Trairak
Somparn, Poorichaya
论文数: 0引用数: 0
h-index: 0
机构:
Chulalongkorn Univ, Ctr Excellence Syst Biol, Fac Med, Bangkok 10330, ThailandChulabhorn Royal Acad, Fac Med & Publ Hlth, HRH Princess Chulabhorn Coll Med Sci, Bangkok 10210, Thailand
Somparn, Poorichaya
Tharnpoophasiam, Prapin
论文数: 0引用数: 0
h-index: 0
机构:
Mahidol Univ, Fac Trop Med, Dept Social & Environm Med, Bangkok 10400, ThailandChulabhorn Royal Acad, Fac Med & Publ Hlth, HRH Princess Chulabhorn Coll Med Sci, Bangkok 10210, Thailand
Tharnpoophasiam, Prapin
Worakhunpiset, Suwalee
论文数: 0引用数: 0
h-index: 0
机构:
Mahidol Univ, Fac Trop Med, Dept Social & Environm Med, Bangkok 10400, ThailandChulabhorn Royal Acad, Fac Med & Publ Hlth, HRH Princess Chulabhorn Coll Med Sci, Bangkok 10210, Thailand
Worakhunpiset, Suwalee
Topanurak, Supachai
论文数: 0引用数: 0
h-index: 0
机构:
Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok 10400, Thailand
Mahidol Univ, Fac Trop Med, Ctr Excellence Antibody Res, Bangkok 10400, ThailandChulabhorn Royal Acad, Fac Med & Publ Hlth, HRH Princess Chulabhorn Coll Med Sci, Bangkok 10210, Thailand
机构:
Pfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 02139 USAPfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 02139 USA
Rieger, Theodore R.
Allen, Richard J.
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 02139 USAPfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 02139 USA
Allen, Richard J.
Musante, Cynthia J.
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 02139 USAPfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 02139 USA
机构:
Pfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 07934 USAPfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 07934 USA
Rieger, Theodore R.
Allen, Richard J.
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 07934 USAPfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 07934 USA
Allen, Richard J.
Musante, Cynthia J.
论文数: 0引用数: 0
h-index: 0
机构:
Pfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 07934 USAPfizer Inc, Quantitat Syst Pharmacol, Early Clin Dev, Cambridge, MA 07934 USA